Literature DB >> 18723575

Time-independent maternal and infant factors and time-dependent infant morbidities including HIV infection, contribute to infant growth faltering during the first 2 years of life.

Aimee L Webb1, Karim Manji, Wafaie W Fawzi, Eduardo Villamor.   

Abstract

Studies investigating the predictors of growth in infants born to HIV-infected women in developing countries are limited. Using data from 886 Tanzanian HIV-infected women and their infants, we examined the impact of maternal socioeconomic and immunological status, infant characteristics at birth, and HIV, diarrhea and respiratory infections on infants' monthly length-for-age (LAZ) and length-for-weight (WLZ) z-scores during the first 2 years of life. We used restricted cubic splines to estimate average adjusted growth curves by categories of each predictor. LAZ decreased significantly during the first 2 years. WLZ increased from birth to 4 months but decreased significantly thereafter. Greater maternal schooling significantly reduced deterioration in LAZ and WLZ scores from birth to 24 months, while maternal CD4 cell counts >or=200 mm(-3) at baseline were associated with reduced deterioration in LAZ scores. Infants born pre-term or with low-birth weight were significantly more stunted and wasted than their reference groups at all time points though their rate of growth faltering was slower. Infant-HIV status was strongly associated with significantly greater deterioration in LAZ and WLZ scores, beginning at about 4 months of age. Episodes of diarrhea or respiratory infections were related to significantly lower WLZ but not LAZ scores, independent of infant-HIV status. In conclusion, maternal schooling, immunological status and infant infections are important predictors of early growth in children born to HIV-positive women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723575      PMCID: PMC2734313          DOI: 10.1093/tropej/fmn068

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  21 in total

1.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

2.  Factors affecting the duration of exclusive breastfeeding among HIV-infected and -uninfected women in Lusaka, Zambia.

Authors:  Molly Chisenga; Lackson Kasonka; Mpundu Makasa; Moses Sinkala; Chifumbe Chintu; Christine Kaseba; Francis Kasolo; Andrew Tomkins; Susan Murray; Suzanne Filteau
Journal:  J Hum Lact       Date:  2005-08       Impact factor: 2.219

3.  Vitamin supplementation of HIV-infected women improves postnatal child growth.

Authors:  Eduardo Villamor; Elmar Saathoff; Ronald J Bosch; Ellen Hertzmark; Ana Baylin; Karim Manji; Gernard Msamanga; David J Hunter; Wafaie W Fawzi
Journal:  Am J Clin Nutr       Date:  2005-04       Impact factor: 7.045

4.  Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission.

Authors:  Sandra Albrecht; Katherine Semrau; Prisca Kasonde; Moses Sinkala; Chipepo Kankasa; Cheswa Vwalika; Grace M Aldrovandi; Donald M Thea; Louise Kuhn
Journal:  J Acquir Immune Defic Syndr       Date:  2006-01-01       Impact factor: 3.731

5.  Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993.

Authors:  P Lepage; P Msellati; D G Hitimana; A Bazubagira; C Van Goethem; A Simonon; E Karita; L Dequae-Merchadou; P Van de Perre; F Dabis
Journal:  Pediatr Infect Dis J       Date:  1996-06       Impact factor: 2.129

6.  Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo.

Authors:  R C Bailey; M C Kamenga; M J Nsuami; P Nieburg; M E St Louis
Journal:  Int J Epidemiol       Date:  1999-06       Impact factor: 7.196

7.  Rationale and design of the Tanzania Vitamin and HIV Infection Trial.

Authors:  W W Fawzi; G I Msamanga; D Spiegelman; E J Urassa; D J Hunter
Journal:  Control Clin Trials       Date:  1999-02

8.  Child mortality in relation to HIV infection, nutritional status, and socio-economic background.

Authors:  Eduardo Villamor; Lara Misegades; Maulidi R Fataki; Roger L Mbise; Wafaie W Fawzi
Journal:  Int J Epidemiol       Date:  2005-01-13       Impact factor: 7.196

Review 9.  Parental education and child health: intracountry evidence.

Authors:  S H Cochrane; J Leslie; D J O'Hara
Journal:  Health Policy Educ       Date:  1982-03

10.  The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.

Authors:  T E Taha; G A Dallabetta; J K Canner; J D Chiphangwi; G Liomba; D R Hoover; P G Miotti
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

View more
  15 in total

1.  Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants.

Authors:  Emily L Deichsel; Patricia B Pavlinac; Barbra A Richardson; Dorothy Mbori-Ngacha; Judd L Walson; Christine J McGrath; Carey Farquhar; Rose Bosire; Elizabeth Maleche-Obimbo; Grace C John-Stewart
Journal:  Matern Child Nutr       Date:  2019-08-06       Impact factor: 3.092

2.  New insights on growth trajectory in infants with complex congenital heart disease.

Authors:  Amy Jo Lisanti; Jungwon Min; Nadya Golfenshtein; Chitra Ravishankar; John M Costello; Liming Huang; Desiree Fleck; Barbara Medoff-Cooper
Journal:  J Pediatr Nurs       Date:  2022-05-20       Impact factor: 2.523

3.  Determinants of growth in HIV-exposed and HIV-uninfected infants in the Kabeho Study.

Authors:  Charlotte E Lane; Emily A Bobrow; Diuedonne Ndatimana; Gilles F Ndayisaba; Linda S Adair
Journal:  Matern Child Nutr       Date:  2019-01-29       Impact factor: 3.092

Review 4.  Patterns of postnatal growth in HIV-infected and HIV-exposed children.

Authors:  Sheila Isanaka; Christopher Duggan; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2009-06       Impact factor: 7.110

5.  Maternal HIV is associated with reduced growth in the first year of life among infants in the Eastern region of Ghana: the Research to Improve Infant Nutrition and Growth (RIING) Project.

Authors:  Anna Lartey; Grace S Marquis; Robert Mazur; Rafael Perez-Escamilla; Lucy Brakohiapa; William Ampofo; Daniel Sellen; Seth Adu-Afarwuah
Journal:  Matern Child Nutr       Date:  2012-08-20       Impact factor: 3.092

6.  Challenges in infant and young child nutrition in the context of HIV.

Authors:  Tin Tin Sint; Ronnie Lovich; Wendy Hammond; Maria Kim; Sara Melillo; Lydia Lu; Pamela Ching; Jennifer Marcy; Nigel Rollins; Emilia H Koumans; Amie N Heap; Margaret Brewinski-Isaacs
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

7.  Lipid-based nutrient supplements are feasible as a breastmilk replacement for HIV-exposed infants from 24 to 48 weeks of age.

Authors:  Valerie L Flax; Margaret E Bentley; Charles S Chasela; Dumbani Kayira; Michael G Hudgens; Kopekani Z Kacheche; Charity Chavula; Athena P Kourtis; Denise J Jamieson; Charles M van der Horst; Linda S Adair
Journal:  J Nutr       Date:  2013-03-06       Impact factor: 4.798

8.  Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia.

Authors:  Stephen Arpadi; Ashraf Fawzy; Grace M Aldrovandi; Chipepo Kankasa; Moses Sinkala; Mwiya Mwiya; Donald M Thea; Louise Kuhn
Journal:  Am J Clin Nutr       Date:  2009-06-24       Impact factor: 7.045

9.  Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India.

Authors:  Malathi Ram; Nikhil Gupte; Uma Nayak; Aarti A Kinikar; Mangesh Khandave; Anita V Shankar; Jayagowri Sastry; Robert C Bollinger; Amita Gupta
Journal:  BMC Infect Dis       Date:  2012-10-31       Impact factor: 3.090

10.  Predictors of stunting, wasting and underweight among Tanzanian children born to HIV-infected women.

Authors:  C M McDonald; R Kupka; K P Manji; J Okuma; R J Bosch; S Aboud; R Kisenge; D Spiegelman; W W Fawzi; C P Duggan
Journal:  Eur J Clin Nutr       Date:  2012-10-03       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.